Category: Treatment
Joe Biden still testing positive for Covid after two weeks
US President Joe Biden is testing positive for Covid-19 two weeks after his initial infection according to his physician.… ...More...
Joe Biden Paxlovid rebound
US President Joe Biden has tested positive for Covid-19 again – only days after testing negative.… ...More...
US President Joe Biden has Covid-19 *1 update*
Biden, 79, is experiencing fatigue, a runny nose and a dry cough after testing positive.… ...More...
Preprint: Bergamottin exhibits inhibitory activity against SARS-CoV-2
Here, we reported that bergamottin, a furanocoumarin originally found in bergamot, exhibited inhibitory activity against SARS-CoV-2 in vitro, ex vivo, and in vivo.… ...More...
Science Mag: SARS-CoV-2 already finding ways to evade Paxlovid
New lab studies shows that SARS-CoV-2 can mutate in ways that make it less susceptible to Paxlovid.… ...More...
Long Covid: Microscopic abnormality in the way oxygen moves from the lungs into the blood vessels
A team of researchers based at five centres across Ontario have zeroed in on a microscopic abnormality in the way oxygen moves from the lungs and into the blood vessels of long COVID patients in their trial.… ...More...
Anthony Fauci Paxlovid rebound
Anthony Fauci has been talking about his recent Covid infection, and seeing the infection rebound after a course of Paxlovid.… ...More...
Pfizer: Paxlovid not effective in reducing symptoms in standard risk patients
Pfizer: “An updated analysis from 1,153 patients showed a non-significant 51% relative risk reduction”.… ...More...
Monkeypox vaccine MVA repurposed for Covid-19
A new comparison study in PNAS from NIAID intramural scientists clearly shows that for SARS-CoV-2, nasal vaccination – particularly in two doses – has clear advantages over muscular delivery in laboratory mice.… ...More...
Monkeypox: “We don’t know the efficacy of any of these monkeypox vaccines”
“How well MVA really protects humans from monkeypox is uncertain.… ...More...
FDA on Paxlovid rebound: “there is no evidence of benefit at this time for a longer course of treatment”
The US FDA have issued a thinly veiled rebuke to Pfizer CEO Albert Bourla, after his recent comments to Bloomberg News about Covid-19 infections rebounding after treatment with Paxlovid.… ...More...
Paxlovid: Virologic characterization of nirmatrelvir-ritonavir rebound
“Symptomatic relapse after nirmatrelvir-ritonavir therapy for early stage COVID-19 infection is associated with high viral load.”…… ...More...
Lancet: Where is the next SARS-CoV-2 variant of concern?
“Curing COVID-19 infections in immunocompromised individuals is of crucial importance.”…… ...More...
Preprint: Covid vaccination is not associated with improvement in Long Covid
The study included 453 COVID-19 patients with post-acute sequelae of COVID (PASC), of which 324 (72%) were vaccinated between the baseline and 6-month visit.… ...More...